Left main coronary artery disease treated with beating heart surgery: 10-year single center results

Tomasz K Urbanowicz1, Michał Michalak2, Anna Olasińska-Wiśniewska1

  • 1Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland.

Insights

Off-pump coronary artery bypass grafting (CABG) is a safe option for left main disease, showing similar survival to multivessel disease. Female sex and diabetes mellitus are risk factors for mortality after OPCAB surgery.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Atherosclerosis Research

Background:

  • Left main coronary disease is a severe condition treatable by percutaneous or surgical methods.
  • Off-pump coronary artery bypass grafting (OPCAB) is a surgical option, though its utilization has declined.

Purpose of the Study:

  • To compare 10-year survival rates between patients undergoing OPCAB for left main versus multivessel disease.
  • To identify mortality risk factors in patients undergoing OPCAB surgery.

Main Methods:

  • Retrospective analysis of 159 patients (32% left main, 68% multivessel disease).
  • Utilized regression analysis for long-term mortality risk and Kaplan-Meier survival curves.
  • Transit time bypass measurements were employed post-surgery.

Main Results:

  • No significant difference in 10-year mortality between left main and multivessel disease patients treated with OPCAB (HR = 0.93).
  • Female sex (HR = 1.08) and diabetes mellitus (HR = 6.33) were identified as significant risk factors for 10-year mortality.
  • Surgical intervention was for 51 patients with left main disease and 108 with multivessel disease.

Conclusions:

  • Off-pump surgery for left main disease is a safe and effective technique with favorable long-term outcomes compared to multivessel disease.
  • Female sex and diabetes mellitus are potential risk factors impacting long-term mortality following OPCAB surgery.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...